Related references
Note: Only part of the references are listed.Safety, tolerability, pharmacokinetics, pharmacodynamics, bioavailability and food effect of single doses of soticlestat in healthy subjects
Shining Wang et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Deciphering the concepts behind Epileptic encephalopathy and Developmental and epileptic encephalopathy
Ingrid E. Scheffer et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2020)
Changing Landscape of Dravet Syndrome Management: An Overview
Debopam Samanta
NEUROPEDIATRICS (2020)
Dravet Syndrome: A Review of Current Management
James W. Wheless et al.
PEDIATRIC NEUROLOGY (2020)
Cannabidiol improves survival and behavioural co-morbidities of Dravet syndrome in mice
Pabitra Hriday Patra et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice
Toshiya Nishi et al.
SCIENTIFIC REPORTS (2020)
Risk Factors for Sudden Unexpected Death in Epilepsy (SUDEP) and Their Mitigation
Robyn Whitney et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2019)
Identification of a Functional Non-coding Variant in the GABAA Receptor α2 Subunit of the C57BL/6J Mouse Reference Genome: Major Implications for Neuroscience Research
Megan K. Mulligan et al.
FRONTIERS IN GENETICS (2019)
Stiripentol for the treatment of seizures in Dravet syndrome
Krista Eschbach et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2019)
Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions
Lyndsey L. Anderson et al.
EPILEPSIA (2019)
Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation
Ana Ricobaraza et al.
SCIENTIFIC REPORTS (2019)
Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial
Lieven Lagae et al.
LANCET (2019)
Impairments in social novelty recognition and spatial memory in mice with conditional deletion of Scn1α in parvalbumin-expressing cells
Tetsuya Tatsukawa et al.
NEUROBIOLOGY OF DISEASE (2018)
Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). I. Drugs in preclinical and early clinical development
Meir Bialer et al.
EPILEPSIA (2018)
Cognitive outcomes following epilepsy in infancy: A longitudinal community-based study
Helen O'Reilly et al.
EPILEPSIA (2018)
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome
Joshua S. Kaplan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
The synthetic neuroactive steroid SGE-516 reduces seizure burden and improves survival in a Dravet syndrome mouse model
Nicole A. Hawkins et al.
SCIENTIFIC REPORTS (2017)
Screening of conventional anticonvulsants in a genetic mouse model of epilepsy
Nicole A. Hawkins et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2017)
24(S)-Hydroxycholesterol as a Modulator of Neuronal Signaling and Survival
Min-Yu Sun et al.
NEUROSCIENTIST (2016)
Treatment of Dravet Syndrome
Elaine C. Wirrell
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2016)
Endogenous 24S-hydroxycholesterol modulates NMDAR-mediated function in hippocampal slices
Min-Yu Sun et al.
JOURNAL OF NEUROPHYSIOLOGY (2016)
Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq
Nicole A. Hawkins et al.
PLOS GENETICS (2016)
Diverse functions of 24(S)-hydroxycholesterol in the brain
Noriko Noguchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Mapping genetic modifiers of survival in a mouse model of Dravet syndrome
A. R. Miller et al.
GENES BRAIN AND BEHAVIOR (2014)
Nav1.1 haploinsufficiency in excitatory neurons ameliorates seizure-associated sudden death in a mouse model of Dravet syndrome
Ikuo Ogiwara et al.
HUMAN MOLECULAR GENETICS (2013)
Sudden unexpected death in a mouse model of Dravet syndrome
Franck Kalume et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
The Major Brain Cholesterol Metabolite 24(S)-Hydroxycholesterol Is a Potent Allosteric Modulator of N-Methyl-D-Aspartate Receptors
Steven M. Paul et al.
JOURNAL OF NEUROSCIENCE (2013)
Mouse with Nav1.1 haploinsufficiency, a model for Dravet syndrome, exhibits lowered sociability and learning impairment
Susumu Ito et al.
NEUROBIOLOGY OF DISEASE (2013)
Efficacy of stiripentol in hyperthermia-induced seizures in a mouse model of Dravet syndrome
Dezhi Cao et al.
EPILEPSIA (2012)
Autistic-like behaviour in Scn1a+/- mice and rescue by enhanced GABA-mediated neurotransmission
Sung Han et al.
NATURE (2012)
Spontaneous epileptiform discharges in a mouse model of Alzheimer's disease are suppressed by antiepileptic drugs that block sodium channels
Sofya Ziyatdinova et al.
EPILEPSY RESEARCH (2011)
Cholesterol 24-Hydroxylase: An Enzyme of Cholesterol Turnover in the Brain
David W. Russell et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2009)
Amyloid β-Induced Neuronal Hyperexcitability Triggers Progressive Epilepsy
Rimante Minkeviciene et al.
JOURNAL OF NEUROSCIENCE (2009)
27-hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen
Michihisa Umetani et al.
NATURE MEDICINE (2007)
Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons:: A circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation
Ikuo Ogiwara et al.
JOURNAL OF NEUROSCIENCE (2007)
Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy
Frank H. Yu et al.
NATURE NEUROSCIENCE (2006)
24S-hydroxycholesterol induces inflammatory gene expression in primary human neural cells
P Alexandrov et al.
NEUROREPORT (2005)
Longitudinal assessment of adaptive behavior in infants and young children with newly diagnosed epilepsy: Influences of etiology, syndrome, and seizure control
AT Berg et al.
PEDIATRICS (2004)
Abnormal anxiety-related behaviour in serotonin transporter null mutant mice: the influence of genetic background
A Holmes et al.
GENES BRAIN AND BEHAVIOR (2003)
Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover
EG Lund et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Anxiety in the elevated zero-maze is augmented in mice after repeated daily exposure
MN Cook et al.
BEHAVIOR GENETICS (2002)
Neurosteroids: biochemistry and clinical significance
SH Mellon et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2002)
Share Paper
